Nota Laboratories

Provider of Nitric oxide-based therapies for chronic rhinosinusitis

placeAnn Arbor, Michigan, United States calendar_todayFounded 2014 groups13 employees language notalabs.com

Innovation

3 patent families (1 granted) — focus: Human necessities; filing pace accelerating. Cited 99 times.

YearFilings
20212
20221
20242
20252

Investor mix

5 investors on record; lead investors include Pegasus Tech Ventures.

Investor typeCountShare
Venture capital360%
Other / undisclosed240%
Coming soon